Stereotactic Surgery Devices Market Growth To Reach USD 24.73 Billion By 2027 Says Reports And Data

Growing demand for minimally invasive surgery is one of the significant factors influencing market growth.

The global stereotactic surgery devices market is expected to reach USD 24.73 Billion by 2027, according to a new report by Reports and Data. Stereotactic surgery is a form of minimally invasive surgical technique used to treat functional defects and small tumors of the brain.

Growing demand for minimally invasive surgery is likely to stimulate market demand. These procedures provide various advantages, such as faster recovery time, lower risk of bleeding, lower risk of pain, lower risk of infection, and smaller scars for patients undergoing surgeries with larger incisions that need removal of parts of the skull. Minimally invasive surgery is meant especially for those patients having tumors and abnormalities that are hard to reach, subject to movement within the body, or located close to vital organs and anatomic regions.

In the first quarter of 2019, it has been estimated that 13,410 men and 10,410 women (23,820 adults) in the U.S. will undergo diagnosis with primary cancerous tumors related to brain and spinal cord. Brain tumors are responsible for 85.0% to 90.0% of all primary CNS (central nervous system) tumors. Moreover, approximately 3,720 children below the age of 15 years will undergo diagnosis in the years 2019. Brain and nervous system cancer occupies the 10^th spot in the leading global cause of death. Also, it has been estimated that 9,910 men and 7,850 women (17,760 adults) will suffer death from primary cancerous brain and central nervous system tumors. Thus, the increasing occurrence of brain tumors are causative in the market growth.

Some of the key players in the market are Elekta AB, Accuracy Inc., Ion Beam Applications SA, Mevion Medical Systems, Micromar, Inomed, Alliance Oncology, Medical AG, Monteris Medical, and Varian Medical Systems Inc., among others.

Request sample copy of this report@ https://www.reportsanddata.com/sample-enquiry-form/2395

Further key findings from the report suggest

• By product type, proton beam radiation therapy contributed to the second-largest market share in 2018 and is expected to grow at a rate of 4.1% in the forecast period. This therapy targets tumors and cancer cells with extreme precision and helps in reducing overall toxicity. Also, it reduces the possibility of severity of short and long term side-effects on healthy tissues and organs in the vicinity, thereby reduces the chances of secondary tumors that may be caused by treatment.
• By application, brain tumor treatment dominated the market in 2018 and is likely to witness a growth rate of 5.8% in the forecast period.
• By end-users, hospitals dominated the market in 2018. The factors including well-resourced operating & diagnostic rooms, higher purchasing power, existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
• North America held the largest market share in 2018 and is estimated to experience a growth rate of 4.1% in the period 2019-2026. The market dominance of North America is owing to the presence of advanced healthcare facilities and increasing acceptance of new technologies in the region.

Quick buy@ https://www.reportsanddata.com/checkout-form/2395

For the purpose of this report, Reports and Data have segmented the global stereotactic surgery devices market on the basis of product type, application, end-users, and region:

Product Type Outlook (Revenue, USD Million; 2016-2027)

• Gamma Knife
• Linear Accelerator
• Proton Beam Radiation Therapy
• Cyber Knife

Application Outlook (Revenue, USD Million; 2016-2027)

• Brain Tumor Treatment
• Arteriovenous Malformations Treatment
• Parkinson’s Disease Treatment
• Epilepsy Treatment
• Others

End-Users Outlook (Revenue, USD Million; 2016-2027)

• Hospitals
• Laboratories

Regional Outlook (Revenue in USD Million; 2016–2026)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia-Pacific
• Middle East & Africa (MEA)
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/2395

Table of Content:

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

    3.1. Increasing inclination of doctors and nurses

Chapter 4. Stereotactic Surgery Devices Market Segmentation & Impact Analysis

    4.1. Stereotactic Surgery Devices Segmentation Analysis

    4.2. Stereotactic Surgery Devices Market Value Chain Analysis, 2016-2026

    4.3. Regulatory framework

Continue…

Request for customization@ https://www.reportsanddata.com/request-customization-form/2395

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements. 

Read More Related Reports:-

Tumor Ablation Market Revenues

Medical Oxygen Concentrators Market Projections

Auditory Brainstem Implant Market Top Companies

IoT in Healthcare Market Revenue

Non-Invasive Brain Trauma Monitoring Devices Market Sales

Tags: Reports and Data, Stereotactic Surgery Devices Market outlook, Stereotactic Surgery Devices Market forecast, Stereotactic Surgery Devices Market share, Stereotactic Surgery Devices Market size, Stereotactic Surgery Devices Market

The post Stereotactic Surgery Devices Market Growth To Reach USD 24.73 Billion By 2027 Says Reports And Data appeared first on Financial Market Brief.